Analysts Estimates and Ratings Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD) and Dynavax Technologies Corporation(NASDAQ:DVAX)

0
5

Ironwood Pharmaceuticals, Inc. (IRWD) will report its next earnings on Feb 05 BMO. The company reported the earnings of $-0.38/Share in the last quarter where the estimated EPS by analysts was $-0.17/share. The difference between the expected and actual EPS was $-0.21/share, which represents an Earnings surprise of -123.5%.

Many analysts are providing their Estimated Earnings analysis for Ironwood Pharmaceuticals, Inc. and for the current quarter 7 analysts have projected that the stock could give an Average Earnings estimate of $-0.16/share. These analysts have also projected a Low Estimate of $-0.21/share and a High Estimate of $-0.08/share.

In case of Revenue Estimates, 10 analysts have provided their consensus Average Revenue Estimates for Ironwood Pharmaceuticals, Inc. as 95.83 Million. According to these analysts, the Low Revenue Estimate for Ironwood Pharmaceuticals, Inc. is 89.5 Million and the High Revenue Estimate is 105 Million. The company had Year Ago Sales of 94.21 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for IRWD to be -7.1%. They are projecting Next Quarter growth of 122.22%. For the next 5 years, Ironwood Pharmaceuticals, Inc. is expecting Growth of 122.49% per annum, whereas in the past 5 years the growth was -8.6% per annum.

Some buy side analysts are also providing their Analysis on Ironwood Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Ironwood Pharmaceuticals, Inc. might touch $18 high while the Average Price Target and Low price Target is $14.29 and $10 respectively.

Ironwood Pharmaceuticals, Inc. closed its last trading session at $12.32 with the gain of 1.95%. The Market Capitalization of the company stands at 1.83 Billion. The Company has 52-week high of $21.20 and 52-week low of $9.07. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 16.84% where SMA50 and SMA200 are 4.22% and -24.15% respectively. The Company Touched its 52-Week High on 07/13/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 1.08 and Average Volume (3 months) is 1.57 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -46.1%. The Return on Equity (ROE) value stands at 408.6%. While it’s Return on Investment (ROI) value is -19.4%.

While looking at the Stock’s Performance, Ironwood Pharmaceuticals, Inc. currently shows a Weekly Performance of 27.13%, where Monthly Performance is 2.11%, Quarterly performance is -28.39%, 6 Months performance is -36.88% and yearly performance percentage is -11.36%. Year to Date performance value (YTD perf) value is 21.24%. The Stock currently has a Weekly Volatility of 7.15% and Monthly Volatility of 7.29%.

Dynavax Technologies Corporation (DVAX) will report its next earnings on Feb 04 AMC. The company reported the earnings of $-0.65/Share in the last quarter where the estimated EPS by analysts was $-0.57/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -14%.

Many analysts are providing their Estimated Earnings analysis for Dynavax Technologies Corporation and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.61/share. These analysts have also projected a Low Estimate of $-0.67/share and a High Estimate of $-0.58/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Dynavax Technologies Corporation as 3.4 Million. According to these analysts, the Low Revenue Estimate for Dynavax Technologies Corporation is 2.97 Million and the High Revenue Estimate is 4 Million. The company had Year Ago Sales of 21 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for DVAX to be -39.5%. They are projecting Next Quarter growth of 3.17%. For the next 5 years, Dynavax Technologies Corporation is expecting Growth of 28.59% per annum, whereas in the past 5 years the growth was -45.09% per annum.

Some buy side analysts are also providing their Analysis on Dynavax Technologies Corporation, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Dynavax Technologies Corporation might touch $32 high while the Average Price Target and Low price Target is $28.25 and $25 respectively.

Dynavax Technologies Corporation closed its last trading session at $10.38 with the gain of 1.35%. The Market Capitalization of the company stands at 659.08 Million. The Company has 52-week high of $22.80 and 52-week low of $7.85. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 9.45% where SMA50 and SMA200 are -2.18% and -24.68% respectively. The Company Touched its 52-Week High on 04/16/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 1.23 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -57.7%. The Return on Equity (ROE) value stands at -98.6%. While it’s Return on Investment (ROI) value is -48.1%.

While looking at the Stock’s Performance, Dynavax Technologies Corporation currently shows a Weekly Performance of 15.86%, where Monthly Performance is -3.22%, Quarterly performance is -5.99%, 6 Months performance is -30.33% and yearly performance percentage is -40.06%. Year to Date performance value (YTD perf) value is 14.97%. The Stock currently has a Weekly Volatility of 5.89% and Monthly Volatility of 7.63%.

SHARE